WO2004089982A3 - April variants and methods thereof - Google Patents

April variants and methods thereof Download PDF

Info

Publication number
WO2004089982A3
WO2004089982A3 PCT/US2004/010254 US2004010254W WO2004089982A3 WO 2004089982 A3 WO2004089982 A3 WO 2004089982A3 US 2004010254 W US2004010254 W US 2004010254W WO 2004089982 A3 WO2004089982 A3 WO 2004089982A3
Authority
WO
WIPO (PCT)
Prior art keywords
april
methods
variants
baff
proteins
Prior art date
Application number
PCT/US2004/010254
Other languages
French (fr)
Other versions
WO2004089982A2 (en
Inventor
John Rudolph Desjarlais
Eugene Zhukovsky
Original Assignee
Xencor Inc
John Rudolph Desjarlais
Eugene Zhukovsky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/338,083 external-priority patent/US20030166559A1/en
Application filed by Xencor Inc, John Rudolph Desjarlais, Eugene Zhukovsky filed Critical Xencor Inc
Publication of WO2004089982A2 publication Critical patent/WO2004089982A2/en
Publication of WO2004089982A3 publication Critical patent/WO2004089982A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to novel proteins of APRIL variants that modulate the biological activity as compared to naturally occurring APRIL or BAFF and nucleic acids encoding these proteins. The invention further relates to the use of the novel proteins in the treatment of BAFF or APRIL-related disorders.
PCT/US2004/010254 2003-01-06 2004-03-31 April variants and methods thereof WO2004089982A2 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US10/338,083 US20030166559A1 (en) 2002-01-04 2003-01-06 Dominant negative proteins and methods thereof
US45909703P 2003-03-31 2003-03-31
US60/459,097 2003-03-31
US48208103P 2003-06-23 2003-06-23
US60/482,081 2003-06-23
US52388003P 2003-11-20 2003-11-20
US60/523,880 2003-11-20
US52810403P 2003-12-08 2003-12-08
US60/528,104 2003-12-08

Publications (2)

Publication Number Publication Date
WO2004089982A2 WO2004089982A2 (en) 2004-10-21
WO2004089982A3 true WO2004089982A3 (en) 2005-04-21

Family

ID=33556741

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/010254 WO2004089982A2 (en) 2003-01-06 2004-03-31 April variants and methods thereof

Country Status (1)

Country Link
WO (1) WO2004089982A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005530482A (en) 2002-01-04 2005-10-13 ゼンコー・インコーポレイテッド Dominant negative proteins and their use
US7381792B2 (en) 2002-01-04 2008-06-03 Xencor, Inc. Variants of RANKL protein
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
WO2005113598A2 (en) * 2004-05-21 2005-12-01 Xencor, Inc. Tnf super family members with altered immunogenicity
EA015860B1 (en) 2005-10-13 2011-12-30 Хьюман Дженом Сайенсиз, Инк. Methods for treatment of autoimmune diseases using neutrokine-alpha antagonist
US8735347B2 (en) * 2011-02-02 2014-05-27 Children's Hospital Medical Center Regulation of energy metabolism and obesity by modulating B cell activating factor (BAFF, BLYS) or BAFF signaling
CN106414502A (en) 2014-02-27 2017-02-15 Ucl商务股份有限公司 April variants

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999012965A2 (en) * 1997-09-12 1999-03-18 Biogen, Inc. April- a novel protein with growth effects

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999012965A2 (en) * 1997-09-12 1999-03-18 Biogen, Inc. April- a novel protein with growth effects

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE SWISSPROT EMBL; XP002312382, retrieved from EBI Database accession no. O75888 *
HAHNE M ET AL: "APRIL, a new ligand of the tumor necrosis factor family, Stimulates tumor cell growth", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 188, 21 September 1998 (1998-09-21), pages 1185 - 1190, XP002093077, ISSN: 0022-1007 *

Also Published As

Publication number Publication date
WO2004089982A2 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
EP2039762A3 (en) Nitralases
WO2001064889A3 (en) Tnf-alpha variants for the treatment of tnf-alpha related disorders
WO2003057856A3 (en) Dominant negative proteins and methods thereof
WO2000053776A3 (en) Human kallikrein-like genes
WO2004081229A3 (en) Use of bv8 and/or eg-vegf to promote hematopoiesis
WO2004089982A3 (en) April variants and methods thereof
WO2007134350A8 (en) Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases
WO2003070169A3 (en) Aminodiphosphonate apolipoprotein e modulators
WO2005110460A3 (en) Diagnosis and treatment methods related to aging, especially in muscle (14.1)
EP2327723A3 (en) Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
WO2005011728A3 (en) Use of soluble cd164 in inflammatory and/or autoimmune disorders
EP1383871A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
EP1385991A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
EP1383908A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
EP1383877A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
WO2003094852A3 (en) Hydroxyphosphonates and phosphonophosphates as apolipoprotein e modulators
WO2008033374A3 (en) Ocl-2a3 compositions and uses thereof
EP1383876A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2003241361A8 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2005074968A3 (en) Medical use of basic peptides
AU2003222241A8 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
EP1377599A4 (en) Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
EP1383882A4 (en) Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
WO2002062845A3 (en) Adhesion molecules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase